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Mycobactins are a family of membrane-associated siderophores
required for Mycobacterium tuberculosis to adapt to its intracel-
lular habitat. These lipophilic siderophores have been recently
shown to directly acquire intracellular iron through lipid traffick-
ing. Despite tremendous progress in understanding the assembly-
line enzymology of the siderophore biosynthesis, the genes as well
as the mechanistic and biochemical principles involved in produc-
ing membrane-associated siderophores have not been investi-
gated. Here, we report a biosynthetic locus that incorporates
variety of aliphatic chains on the mycobactin skeleton. Cell-free
reconstitution studies demonstrate that these acyl chains are
directly transferred from a carrier protein on to the -amino group
of lysine residue by an unidentified Rv1347c gene product. The
unsaturation in the lipidic chain is produced by a novel acyl-acyl
carrier protein dehydrogenase, which, in contrast to the conven-
tional acyl-CoA dehydrogenases, is involved in the biosynthetic
pathway. MbtG protein then performs the final N6-hydroxylation
step. Genome-wide analysis revealed homologues of N-acyl trans-
ferase and MbtG in other pathogenic bacteria. Because iron plays
a key role in the development of infectious diseases, the biosyn-
thetic pathway described here represents an attractive target for
developing new antibacterial agents.
biosynthesis  mycobactin  siderophore  acyl-transferase  dehydrogenase
Many bacterial pathogens, due to limited availability of freeiron in the host, secrete siderophores to establish and
maintain infection. Because iron is an essential cofactor for
several enzymatic processes, restricting the availability of iron is
an important strategy for defense against bacterial infections (1,
2). Siderophores are typically low molecular weight peptidic
metabolites that are specifically induced in response to low iron
concentrations (3, 4). To date, several hundred siderophores
have been isolated and characterized that vary considerably in
chemical composition. In recent years a novel family of cell-
associated amphiphilic siderophores has been recognized in
marine bacteria (5, 6) (Fig. 1). Interestingly, such membrane-
associated siderophores that contain a lipidic side chain attached
to a polar head group were first characterized frommycobacteria
several years ago (7). The availability of microbial genome
sequences has propelled our understanding of the assembly-line
enzymology of siderophore biosynthesis (8). However, the mo-
lecular components of the biosynthetic machinery involved in
the assembly of lipophilic siderophores remain to be elucidated.
Mycobacterium tuberculosis, which survives within the phago-
somes of macrophages, competes for host iron by producing both
soluble and lipophilic iron acquisition systems (9, 10). Mycobac-
tins have been considered to be intra-envelope short-term
storage molecules that interact with soluble carboxymycobactins
for accessing host iron pools (11). In a recent study, the lipophilic
mycobactins were shown to directly acquire intracellular iron
through lipid trafficking (12). It has been proposed that the ferric
mycobactins preferentially localize at lipid droplets, which are
then delivered to phagosomes. The apo-form of mycobactin
supposedly folds into a more compact spherical head group upon
iron binding, which results in the decreased membrane affinity
of the siderophore. Previous studies of the interactions of the
amphiphilic siderophore marinobactin E and its iron complexes
with phospholipid vesicles have suggested that the membrane
affinity of siderophores could also be modulated by the unsat-
uration in the fatty acid tail and the carbon chain length (13).
Together, these studies have emphasized the critical function of
lipidic moiety in modulating the membrane permeability and
dynamic diffusibility of lipophilic siderophores that are crucial
for iron sequestration.
Genetic disruption studies along with in vitro characterization
of MbtA and the N-terminal domain of MbtB have confirmed
thatmbt cluster fromM. tuberculosis is involved in production of
siderophores (14, 15). Based on sequence homologies of the
mbt-encoded proteins and the modular logic of nonribosomal
peptide synthetases, a biosynthetic scheme for mycobactin for-
mation has been proposed (9, 10). However, genes encoding the
enzymes responsible for transferring the acyl substitutions of
different aliphatic chain lengths and for introducing unusual cis
double bond conjugated to carbonyl group that distinguish
mycobactin and carboxymycobactin are not found in the mbt
cluster and have not been identified in the mycobacterial ge-
nome. In this study, we have identified a genetic locus involved
in the assembly of mycobactins, which we propose to annotate as
mbt-2. Interestingly, several genes from the mbt-2 cluster were
earlier demonstrated to be essential for the growth of mycobac-
teria (16, 17). Our studies here delineate the biochemical
functions of all these genes. Cell-free reconstitution studies
provide molecular mechanistic insights of how acyl chains are
directly transferred from a carrier protein on to the -amino
group of lysine residue by an unidentified Rv1347c gene product.
The unsaturation in the lipidic chain is produced by an acyl-acyl
carrier protein (ACP) dehydrogenase (FadE14), which, in con-
trast to the conventional acyl-CoA dehydrogenases, is involved
in this biosynthetic pathway. We also demonstrate that MbtG
protein performs the N6-hydroxylation step to generate func-
tionally important hydroxamate moieties. Furthermore, our
genome-wide analysis reveals homologues of N-acyl transferase
(NAT) as well as N6-monooxygenase from several pathogenic
bacteria. This report of the biochemical reconstitution reveals
unique molecular components of siderophore biosynthetic ma-
chinery that are crucial for iron sequestration during bacterial
pathogenesis.
Results
Computational Analysis of Iron-Dependent Genes Regulated by IdeR
Repressor. The transcriptional profiling studies of iron-
dependent genes in M. tuberculosis have revealed several genes
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required for iron acquisition and storage that are regulated by
IdeR repressor (18). Because mbt biosynthetic cluster is regu-
lated by IdeR repressor, we carefully analyzed other genes that
could impart amphiphilicity to mycobactins and whose expres-
sion is modulated by the levels of iron in the growth medium.
One such interesting cluster contains proteins (FadD33 and
FadE14) that showed distinct homology to proteins involved in
lipid metabolism. The disruption of fadD33 gene in M. tubercu-
losisH37Rv had earlier suggested the important role of the gene
product in mycobacterial virulence by supporting its replication
in the liver (17). Computational analysis of FadD33 protein
indicated that this protein was homologous to the newly discov-
ered fatty acyl-AMP ligase (FAAL) proteins from mycobacteria
(19). Our recent biochemical studies showed that these closely
related FadD proteins convert fatty acids into their correspond-
ing acyl adenylates, which are transferred on to the phospho-
pantetheine arm of carrier proteins. Interestingly, Rv1344, the
ORF neighboring fadD33, shows similarity to acyl carrier pro-
tein. FadE14 is homologous to acyl-CoA dehydrogenases that
typically catalyze the dehydrogenation of acyl-CoA thioesters to
the corresponding trans-2-enoyl-CoA (20, 21). The position of
active site Glu residue in the protein sequence is analogous to
typical medium-long-chain acyl-CoA dehydrogenases. The ad-
jacent Rv1347c gene in the mycobacterial genome is transcribed
in the opposite direction and shows homology to aerobactin
siderophore biosynthesis protein IucB (22). The recent deter-
mination of complete genome sequence of Nocardia farcinica
IFM 10152 also revealed a protein with high sequence similarity
to Rv1347c (23). Remarkably, this gene in Nocardia is present
besides other putative siderophore genes. Threading results of
Rv1347c gene product using Genthreader suggested that this
hypothetical protein has homology to histone acetyltransferases
(HATs) (24), which transfer the acetyl group on to the -amino
group of lysine residue. We therefore predicted that this protein
indeed may be involved in the acylation of lysine residues in
mycobactin. In a very recent report, the 3D structure of Rv1347c
gene product was determined as part of the mycobacterial
structural genomics initiative; however, its biological function
has not yet been established (25).
Organization of these four genes across several mycobacterial
species clearly showed complete conservation in Mycobacterium
microti, Mycobacterium avium, Mycobacterium smegmatis, Myco-
bacterium bovis, Mycobacterium marinum, and Mycobacterium
ulcerans, but not in Mycobacterium leprae. Recently, the trans-
poson-mediated mutagenesis in M. smegmatis had indicated an
essential role of Rv1345 gene product in mycobactin biosynthesis
(26). Intriguingly, complementation with corresponding genes
fromM. tuberculosis failed to restore mycobactin synthesis inM.
smegmatis, despite its high degree of sequence homology. To test
our predictions, we decided to directly probe the biochemical
functions of all these proteins by cell-free reconstitution studies.
Biochemical Investigations of the New mbt Cluster: FadD33 Activates
Lipidic Moieties Required for Mycobactin Biosynthesis.Expression of
FadD33 protein in Escherichia coli primarily resulted in the
formation of inclusion bodies. Addition of lauroyl sarcosine (10
mM) during cell lysis provided 20–30% protein in soluble
fraction (Fig. 2A). The enzymatic activity of FadD33 was tested
by using a variety of medium-long-chain fatty acids. The
formation of acyl adenylate was confirmed by combination of
HPLC and MS analysis, as described (27). Because there is a
putative ACP (Rv1344) domain present in this cluster, we
explored whether this carrier protein could be charged with
aliphatic fatty acids. In vitro acylations with radiolabeled sub-
strates confirmed that the ACP protein could be posttransla-
tionally modified by promiscuous surfactin phosphopantetheinyl
transferases (sfp) (28). The inclusion of holo-ACP in the FadD33
reaction assays resulted in the formation of lauroylated-ACP
(Fig. 2B). Nanospray MS analysis showed a molecular ion peak
[MH] atmz 14002.82 consistent with molecular formula of
His-tagged lauroyl-ACP protein.
Rv1347c Directly Transfers Long Chain Acyl Moieties from the Carrier
Protein onto the Mycobactin Core. The next step in the assembly of
amphiphilic mycobactin would involve N-acylation of these ACP
tethered long-chain fatty acids directly onto the -amino group
of lysine. We investigated whether Rv1347c protein could per-
form this final catalytic step using substrate mimics. The ben-
zyloxycarbonyl lysine methyl ester (Z-Lys-OMe; I) was chemi-
cally synthesized and was used as surrogate substrate for the
deacylated form of mycobactin (Fig. 2B). The -amino group of
lysine is acylated by benzyloxy carbonyl group and possesses only
a free -amino group. Analysis of the reaction products formed
during the incubation of Z-Lys-OMe along with 14C-lauroyl-CoA
and Rv1347c protein by using radio-TLC showed formation of
two new products with an approximate Rf of 0.5 and 0.4 (kobs 24.5
min1) (Fig. 2C). Thesemetabolites were analyzed onHPLC and
characterized as N6-lauroyl Z-Lys-OMe (II) and N6-lauroyl
Z-Lys-OH by electrospray ionization tandem MS (ESI-MS
MS). The identity of product was also confirmed by the synthesis
of chemical reference. Further investigations with the ACP-
tethered intermediates, instead of acyl-CoAs, showed good
Fig. 1. Structures of amphiphilic siderophores: Mycobactin from M. tuber-
culosis, marinobactin fromMarinobacter sp., aquachelin fromH. aquamarina,
and amphibactin from Vibrio sp. R-10.
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catalytic rates for the formation of N6-lauroyl Z-Lys-OMe, and
MS analysis showed molecular ion peak [M  H]1 at 477.31
(Fig. 2D). The comparison of steady-state kinetic parameters for
the formation of lauroyl-Lys products by using lauroyl-CoA and
lauroyl-ACP substrates suggested an apparent KM of 34 M and
0.72 M, respectively (Fig. 2 E and F). This 50-fold difference
between the affinities for these two substrates clearly demon-
strates that Rv1347c protein prefers ACP-bound substrates over
CoA-esters. Examination of substrate specificity showed that this
protein could transfer a wide range of medium- to long-chain
fatty acids (C6–C16). Kinetic analysis with Rv1347c clearly
showed higher specificity for long-chain fatty acyl-CoAs, as
compared with their KM values (Table 1).
FadE14 Is an Acyl-ACP Dehydrogenase. Because Rv1347c showed
affinity for ACP-bound intermediates, we wanted to investigate
whether acyl-CoA dehydrogenase homologue FadE14 would
also use similar substrates. The catalytic cycle of acyl-CoA
dehydrogenase results in the simultaneous reduction of cofactor
FAD to FADH2. To regenerate the oxidized form of the
cofactor, the two widely used electron acceptors phenazine
methosulfonate (PMS) and ferricenium hexafluorophosphate
(FcPF6) were independently used as in the enzymatic assays
(29). The ACP-tethered substrates showed no activity with PMS,
whereas catalytic turnover was observed with FcPF6 (kobs 120
min1). The inability of PMS to support the catalytic activity was
not investigated further. Because FcPF6 provided robust
activity, this was used in this study. The ,-unsaturated aliphatic
chains bound to ACP were subsequently transferred on to
-amino group of Z-Lys-OMe by using Rv1347c protein (Fig.
3A). The final product was extracted and analyzed by ESI-MS
MS. The TOF-MS spectra clearly showed a molecular ion peak
[M  H] at mz 475.35 (Fig. 3B), which is 2 Da less than the
N6-lauroyl Z-Lys-OMe (II). Furthermore, the collision-based
fragmentation of 475.35 yielded fragments of 367.24 and 181.15,
which could be observed only for dehydrogenated N6-lauroyl
Z-Lys-OMe. These studies clearly demonstrate that FadE14 can
introduce a double bond on the ACP-tethered products.
MbtG Produces Hydroxamate Groups inMycobactin Necessary for Iron
Sequestration.Although the precise order in which terminal steps
would occur in mycobactin biosynthesis is not clear, the recent
isolation of didehydroxymycobactins (DDMs) from the early-
infected cultures of M. tuberculosis had suggested that lysine
hydroxylation may be the final step in the mycobactin assembly
(30). The mbtG gene product from the mbt cluster has been
anticipated to be a lysine N6-hydroxylase (9, 15). Previous
studies withN6-hydroxylase from aerobactin biosynthetic cluster
had suggested that these proteins belong to the family of
flavoprotein monooxygenases and consume molecular oxygen
during catalysis (31, 32). The enzymatic reactions with MbtG
protein were carried out with N6-lauroyl Z-Lys-OMe (II) in the
presence of NADPH and FAD, in air saturated buffers (Fig. 4A).
Under these conditions, MbtG protein showed low catalytic
turnover (kobs 3.2 min1). The MS analysis of the extracted
products showed a molecular ion peak [M  H] at mz 493.48.
The ESI-MSMS yielded fragments, which clearly indicated the
hydroxylated product of the acylated lysine (Fig. 4B). Hydroxy-
lation activity of MbtG protein was also detected with L-lysine.
The competition experiment showed 5-fold preference for using
acetylated lysine over lysine. MbtG protein also displayed spec-
Fig. 2. Activation and transfer of acyl chains onto the -amino group of lysine. (A) SDSPAGE profiles of purified Rv1344 (ACP), FadD33, and Rv1347c proteins.
Two ACP bands were observed corresponding to the apo- and holo-forms of protein. (B) FadD33-mediated activation of fatty acid and transfer onto the
phosphopantetheinylated ACP. The lauroyl moiety bound to the ACP domain is transferred to the -amino group of the Z-lysine-OMe (I) by Rv1347c protein.
(C) Radio-TLC analysis of Rv1347c-catalyzed enzymatic activity yielded two radioactive bands corresponding to N6-lauroyl Z-lysine methyl ester (band A) and
N6-lauroyl Z-lysine (band B). These products were not observed in the absence of the protein. (D) MSMS analysis of N6-lauroyl Z-lysine-OMe (II). The
fragmentation sites are marked in dots on the chemical structure. (E and F) Steady-state kinetic measurements of Rv1347c protein for lauroyl-CoA and
lauroyl-ACP.
Table 1. Steady-state kinetic analysis for Rv1347c protein
Acyl-CoA KM, M
Hexanoyl-CoA 166.20
Decanoyl-CoA 86.12
Lauroyl-CoA 33.93
Palmitoyl-CoA 19.50
Results are means (n  3) with SE values 15%.
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ificity for the side chain amino group and no hydroxylation was
observed at -amino group.
Discussion
Our cell-free reconstitution studies provide evidence for the
direct involvement of this peripheral cluster in the biosynthesis
of mycobactin. We propose to annotate this cluster as mbt-2,
whereas the earlier identified cluster involved in the synthesis of
mycobactin core may be referred to asmbt-1. Both these clusters
are transcriptionally regulated by iron concentrations using IdeR
repressor. We show that the mbt-2 cluster dictates the incorpo-
ration of lipophilic aliphatic chain to produce amphiphilic me-
tabolites (Fig. 5). Based on the existing nomenclature, the four
genes from this cluster can be annotated as mbtK, mbtL, mbtM,
and mbtN for Rv1347c, Rv1344, fadD33, and fadE14, respec-
tively. It is interesting to note that even the tailoring steps in the
mycobactin biosynthesis proceed on acyl-S-enzyme intermedi-
ates. The preferred utilization of acyl-S-enzyme intermediates by
MbtK and MbtN may be an efficient method to channelize
substrates and thereby provide an effective mechanism to gen-
erate specificity during the biosynthesis of metabolites.
It is worthwhile to note that both mbtK and mbtG genes were
found to be essential for the growth of M. tuberculosis in a
genome-wide mutational analysis (33). Homologues of these two
genes could also be identified from various other pathogenic
organisms, including Burkholderia cepacia, Pseudomonas, No-
cardia, Acetinobacter, and Sinorhizobium meliloti. Structural
analysis of N-acyl transferase proteins from different organisms
suggested variations in the acyl chain-binding pocket. Interest-
ingly, Nocardia farcinica produces siderophore nocobactin that
differs frommycobactin primarily in terms of acetyl modification
at the lysine residue. Ourmolecular modeling studies suggest two
crucial aliphatic residues (Pro145 and Ala183) in the substrate-
binding pocket of MbtK that are replaced to relatively hydro-
philic side chains in Nocardia N-acyl transferase protein. It is
possible that these two residues may be important in determining
the specificity of acyl chain length. However, MbtK protein
showed exclusive specificity to acylate at the -amino position,
and the amino group at -position was not readily modified.
Interestingly, this protein was able to acylate the -position of
ornithine amino acid and also catalyzed transfer of acyl chains
on to gramicidin S, which contains two ornithine residues.
In an earlier study, an acyl-CoA dehydrogenase homologue
(FkbI) from FK520 PKS cluster was speculated to use ACP-
bound substrates, based on its 3D structure (34). However, no
confirmation for such a catalytic activity was established. In this
study, we have characterized an acyl-ACP dehydrogenase activ-
ity for MbtN protein that is involved in the biosynthesis of a
metabolite. This result is in contrast to widely distributed
CoA-using acyl-CoA dehydrogenases that are primarily involved
in -oxidation degradative pathway (20, 21). Because acyl-CoA
dehydrogenases, in general, are known to catalyze formation of
trans-isomer and mycobactins contains a cis double bond, it
would be worthwhile to investigate the stereochemistry of
FadE14 reaction. It would be interesting to study whether
protein–protein interactions between ACP and FadE14 might
facilitate the formation of an unusual geometry at the -
position. Bioinformatics analysis of the mycobacterial genome
Fig. 3. Enzymatic activity of FadE14 protein. (A) FadE14 catalyzes the
dehydrogenation at the - position of ACP-bound acyl chains, which can be
further transferred to Z-lysine-OMe (I) by Rv1347c protein to produce (III). (B)
TandemMS analysis of the dehydrogenated product (III). (C) FadE14 could be
purified to homogeneity as a 41-kDa protein.
Fig. 4. Hydroxylation of -amino group of lysine. (A) MbtG is a flavoprotein
monooxygenase that utilizes FAD and NADPH as cofactors to perform hy-
droxylation reactions. (B) Positive ion MS analysis of the product (IV) gener-
ated a molecular ion at 493.48. The MSMS produced mz peak at 311.31,
which is obtained by the loss of the lauroyl moiety. Some of the other
fragment ions generated during collisional fragmentation are also shown
here. (C) SDSPAGE of purified MbtG protein.
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did not reveal any apparent cis-trans isomerase in the proximity
of these two mbt clusters.
MbtG belongs to flavoprotein monooxygenases that generate
hydroxamate unit, a common iron-binding functional group
present in siderophores. Homologues of MbtG proteins are
present in a number of siderophore-producing organisms. Dis-
ruption of these monooxygenases in Burkholderia cepacia, As-
pergillus nidulans and Aspergillus fumigatus results in loss of
effective persistence and colonization and has been proposed to
be absolutely essential for virulence (35, 36). In B. cepacia, the
siderophore biosynthesis was partially restored by addition of
N-hydroxy ornithine to the cultures (37). Interestingly, the
didehydroxy analog of mycobactin siderophore has been recently
isolated from mycobacteria, suggesting that hydroxylation may
be the last step in biosynthesis (30). It is interesting to note that
the mechanism of N-hydroxylations along with nonribosomal
biosynthesis of siderophore backbone has been conserved
throughout the bacterial evolution and may indicate the role of
lateral gene transfer in the siderophore biosynthetic pathway.
Because iron plays a key role in the development of infectious
diseases, the biosynthetic enzymes described in this study rep-
resent outstanding candidates as targets for developing antibac-
terial agents against tuberculosis and related bacterial diseases.
Materials and Methods
A bacterial artificial chromosome library of M. tuberculosis
H37Rvwas obtained from the Pasteur Research Institute (Paris).
Radioactive materials were purchased from Amersham Phar-
macia Biosciences, PerkinElmer, and American Radiolabeled
Chemicals (St. Louis). All other chemicals used were of analyt-
ical grade and were purchased from Sigma, New England
Biolabs, Stratagene, and Merck.
Cloning, Expression, and Purification. Primers used for cloning
various genes are as follows: fadE14 (5-CATATGACGGCCG-
GCTCCGACCTC-3 and 5-GAATTCGCTTTGGAAGCTC-
CGAC-3); fadD33 (5-CATATGAGTGAGCTCGCGGC-
CGTG-3 and 5-GAATTCTCAGTCCGCCATCTCCAGGGA
3); ACP (5-CATATGTGGCGATATCCACTAAGT-3 and 5-
GAATTCTCAGAGCGGTATTTGGC-3); Rv1347c (5-
CATATGACCAAACCCACATCCGCT-3 and 5-GAATTCG-
CAGCCGTGGTCGGAGC-3; and mbtG (5-CATATG-
AATCCGACGCTCGCGGTC-3 and 5-GAATTCTCAGCTA-
AAGGATTGGTGCTC-3). These primers with engineered
NdeI and EcoRI sites (italicized) were used to amplify the
relevant genes by using a bacterial artificial chromosome
genomic library. The fadE14, ACP, and Rv1347c were cloned in
NdeI-EcoRI sites on pET21c for expression with C-terminal
hexa-His-tag. The mbtG and fadD33 were cloned in pET28c for
expression as N-terminal hexa-His tag. All proteins were ex-
pressed by using BL21-DE3 strain of E. coli. Proteins were
obtained in the soluble fraction by inducing cultures at low
temperatures and IPTG concentrations. Expression of FadD33
protein in E. coli primarily resulted in the formation of inclusion
bodies. Addition of lauroyl sarcosine (10 mM) during cell lysis
provided 20–30% proteins in soluble fraction. These proteins
were purified by Ni2-NTA affinity chromatography followed by
anion exchange chromatography by using the AKTA (Amer-
sham Pharmacia) chromatographic system. All proteins were
purified to 97% homogeneity.
Enzyme Assays for FadD33.The enzymatic activity of FadD protein
was analyzed by radio-TLC and HPLC, as described (18).
Formation of acyl adenylate was confirmed by using ESI-MS.
Acylation of ACP. Acylation of mycobacterial Rv1344 holo-ACP
was carried out by using FadD33FadD28 protein, both of which
make acyl adenylates (18). The reaction mixture contained 50
mM Tris (pH 6.8), 10 mM MgCl2, 1 mM Tris-(2-carboxyeth-
yl)phosphine (TCEP), 100 M [14C]lauroyl-CoA, and 5–10 m
ACP. Reactionmixture was incubated for 20min at 30°C, and the
lauorylated-ACP was purified by using Ni2-NTA affinity chro-
matography. This lauroylated-ACP along with Z-lysine-OMe
were used as substrates for Rv1347c protein.
Characterization of Rv1347c. The acylated product of Rv1347c
protein was analyzed by radio-TLC. The reaction mixture in-
cluded 50 mM Tris (pH 8.0), 100 M [14C]acyl CoA, 1 mM
Z-lysine-OMe, and 20 M protein in a 50-l reaction volume.
The reaction was initiated by the addition of Rv1347c protein
and incubated for 30 min at 30°C. The products were extracted
with ethyl acetate, concentrated, and analyzed by TLC by using
a solvent system of 4:1 ethyl acetatehexane. The radiolabeled
product was detected by using PhosphorImager (Fuji BAS5001).
A control reaction without protein was carried out to monitor
the rate of spontaneous acylation of Z-lysine-OMe from acyl-
CoA. Extracted product was analyzed by ESI-MS.
Kinetic Analysis of Rv1347c. Reactions were carried out as de-
scribed above with varying concentrations (15–400 M) of
[14C]acyl-CoAs. Reactions were initiated with the addition of
protein and incubated for 3 min at 30°C. Products were extracted
and resolved on TLC as described above. Fuji BAS5001 Phos-
phorImager was used to quantitate the radiolabeled products.
Chemical Synthesis of Standard. N--benzyloxycarbonyl-L-lysine
methyl ester hydrochloride was synthesized by using standard
Fmoc (9-fluorenylmethoxycarbonyl) chemistry (38) and was
Fig. 5. Biosynthetic scheme of the proposed pathway for amphiphilic mycobactins. During low iron conditions, the IdeR-Fe2 complex is not formed, which
results in the activation of transcription of IdeR-repressed genes (38). The iron box promoters (Fe-box) are found adjacent to both mbt-1 and mbt-2 clusters
whereasmbt-1 gene cluster producesmycobactin skeleton andmbt-2 cluster produces acyl-S-ACP intermediates. These acyl-S intermediates are then transferred
toproducedidehydroxymycobactin in thepresenceofMbtK. Thefinal hydroxylation is carriedout byMbtG togenerate the amphiphilicmycobactin siderophore.
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later on purchased from Novabiochem. N6-lauroyl Z-lysine-
OMe was synthesized by using Schotten-Baumann conditions
(39). Z-lysine-OMe (200 mg, 0.68 mmol) was dissolved in 20 ml
of pyridine, and lauroyl chloride (297 mg, 1.36 mmol) was added
to this solution. The reaction was carried out for 6 h at room
temperature. The product was then extracted with ethyl acetate
and washed with water. The product was first detected by using
TLC and then purified on a C5 reverse phase Phenomenax
HPLC column. Formation of the product was confirmed by MS
analysis, (MH) 477.3328 (C23H16O4N calculated 476.3250).
Enzyme Assay for FadE14. Dehydrogenase activity was carried out
by using PMS and ferricenium hexafluorophosphate as electron
acceptors. The reaction volume consisted of 50 mM Tris (pH
7.6), 0.5 mM lauroyl-ACP, 250 M ferricenium hexafluorophos-
phate (or 3 mM PMS), 100 M FAD, and 30 g of protein. The
reaction was started by the addition of FadE14, and the contents
were incubated for 30 min at 30°C. The dehydrogenated product
was then transferred onto the -amino group of Z-lysine-OMe
mediated by Rv1347c. Products were extracted by using ethyl
acetate and analyzed by MS.
Enzymatic Activity of MbtG. Reactions were carried out with 100
MZ-lauroyl lysine-OMe, 100 mM Tris (pH 7.0), 100 MFAD,
150 M NADPH, and 20 g of MbtG. Contents were incubated
at 30°C for 1 h, extracted with ethyl acetate, and confirmed by
MS. In the competition experiments, lysine concentration was
varied from 75 M to 500 M.
We thank Pooja Arora for technical help and analysis and
Dr. Sandip K. Basu for helpful discussions. M.Z.A. is a Senior Research
Fellow of the Council of Scientific and Industrial Research, India. R.S.G.
is a Wellcome Trust International Senior Research Fellow in India and
also a Howard Hughes Medical Institute International Fellow. This work
was also supported by grants to the National Institute of Immunology by
the Department of Biotechnology (DBT), India.
1. Ferreras, J. A., Ryu, J. S., Di Lello, F., Tan, D. S. & Quadri, L. E. N. (2005)
Nat. Chem. Biol. 1, 29–32.
2. Fluckinger, M., Haas, H., Merschak, P., Glasgow, B. J. & Redl, B. (2004)
Antimicrob. Agents Chemother. 48, 3367–3372.
3. Andrews, S. C., Robinson, A. K. & Rodriguez-Quinones, F. (2003) FEMS
Microbiol. Rev. 27, 215–237.
4. Schaible, U. E. & Kaufmann, S. H. (2004) Nat. Rev. Microbiol. 2, 946–953.
5. Martinez, J. S., Carter-Franklin, J. N., Mann, E. L., Martin, J. D., Haygood,
M. G. & Butler, A. (2003) Proc. Natl. Acad. Sci. USA 100, 3754–3759.
6. Martinez, J. S., Zhang, G. P., Holt, P. D., Jung, H. T., Carrano, C. J., Haygood,
M. G. & Butler, A. (2000) Science 287, 1245–1247.
7. Snow, G. A. (1970) Bacteriol. Rev. 34, 99–125.
8. Crosa, J. H. & Walsh, C. T. (2002) Microbiol. Mol. Biol. Rev. 66, 223–249.
9. De Voss, J. J., Rutter, K., Schroeder, B. G. & Barry, C. E., 3rd (1999) J.
Bacteriol. 181, 4443–4451.
10. Ratledge, C. (2004) Tuberculosis (Edinburgh) 84, 110–130.
11. Gobin, J. & Horwitz, M. A. (1996) J. Exp. Med. 183, 1527–1532.
12. Luo, M., Fadeev, E. A. & Groves, J. T. (2005) Nat. Chem. Biol. 1, 149–153.
13. Xu, G., Martinez, J. S., Groves, J. T. & Butler, A. (2002) J. Am. Chem. Soc. 124,
13408–13415.
14. De Voss, J. J., Rutter, K., Schroeder, B. G., Su, H., Zhu, Y. & Barry, C. E., 3rd.
(2000) Proc. Natl. Acad. Sci. USA 97, 1252–1257.
15. Quadri, L. E., Sello, J., Keating, T. A., Weinreb, P. H. & Walsh, C. T. (1998)
Chem. Biol. 5, 631–645.
16. Sassetti, C. M., Boyd, D. H. & Rubin, E. J. (2003) Mol. Microbiol. 48, 77–84.
17. Rindi, L., Fattorini, L., Bonanni, D., Iona, E., Freer, G., Tan, D., Deho, G.,
Orefici, G. & Garzelli, C. (2002) Microbiology 148, 3873–3880.
18. Rodriguez, G. M. & Smith, I. (2003) Mol. Microbiol. 47, 1485–1494.
19. Trivedi, O. A., Arora, P., Sridharan, V., Tickoo, R., Mohanty, D. & Gokhale,
R. S. (2004) Nature 428, 441–445.
20. Ghisla, S. & Thorpe, C. (2004) Eur. J. Biochem. 271, 494–508.
21. Kim, J. J. & Miura, R. (2004) Eur. J. Biochem. 271, 483–493.
22. de Lorenzo, V., Bindereif, A., Paw, B. H. & Neilands, J. B. (1986) J. Bacteriol.
165, 570–578.
23. Ishikawa, J., Yamashita, A., Mikami, Y., Hoshino, Y., Kurita, H., Hotta, K.,
Shiba, T. & Hattori, M. (2004) Proc. Natl. Acad. Sci. USA 101, 14925–14930.
24. McGuffin, L. J., Bryson, K. & Jones, D. T. (2000) Bioinformatics 16,
404–405.
25. Card, G. L., Peterson, N. A., Smith, C. A., Rupp, B., Schick, B. M. & Baker,
E. N. (2005) J. Biol. Chem. 280, 13978–13986.
26. LaMarca, B. B., Zhu, W., Arceneaux, J. E., Byers, B. R. & Lundrigan, M. D.
(2004) J. Bacteriol. 186, 374–382.
27. Trivedi, O. A., Arora, P., Vats, A., Ansari, M. Z., Tickoo, R., Sridharan, V.,
Mohanty, D. & Gokhale, R. S. (2005) Mol. Cell 17, 631–643.
28. Gokhale, R. S., Tsuji, S. Y., Cane, D. E. & Khosla, C. (1999) Science 284,
482–485.
29. Lehman, T. C., Hale, D. E., Bhala, A. & Thorpe, C. (1990) Anal. Biochem. 186,
280–284.
30. Moody, D. B., Young, D. C., Cheng, T. Y., Rosat, J. P., Roura-Mir, C.,
O’Connor, P. B., Zajonc, D. M., Walz, A., Miller, M. J., Levery, S. B., et al.
(2004) Science 303, 527–531.
31. Stehr, M., Smau, L., Singh, M., Seth, O., Macheroux, P., Ghisla, S. &
Diekmann, H. (1999) Biol. Chem. 380, 47–54.
32. Thariath, A., Socha, D., Valvano, M. A. & Viswanatha, T. (1993) J. Bacteriol.
175, 589–596.
33. Sassetti, C. M., Boyd, D. H. & Rubin, E. J. (2001) Proc. Natl. Acad. Sci. USA
98, 12712–12717.
34. Watanabe, K., Khosla, C., Stroud, R. M. & Tsai, S. C. (2003) J. Mol. Biol. 334,
435–444.
35. Visser, M. B., Majumdar, S., Hani, E. & Sokol, P. A. (2004) Infect. Immun. 72,
2850–2857.
36. Schrettl, M., Bignell, E., Kragl, C., Joechl, C., Rogers, T., Arst, H. N., Jr.,
Haynes, K. & Haas, H. (2004) J. Exp. Med. 200, 1213–1219.
37. Sokol, P. A., Darling, P., Woods, D. E., Mahenthiralingam, E. & Kooi, C.
(1999) Infect. Immun. 67, 4443–4455.
38. Atherton E. & Sheppard, R. C. (1989) Solid Phase Peptide Synthesis: A Practical
Approach (IRL, Oxford).
39. Jass, P. A., Rosso, V. W., Racha, S., Soundararajan, N., Venit, J. J., Rusowicz,
A., Swaminathan, S., Livshitz, J. & Delaney, E. J. (2003) Tetrahedron 59,
9019–9029.
2074  www.pnas.orgcgidoi10.1073pnas.0507924103 Krithika et al.
